NCT02234804View on ClinicalTrials.gov

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
Coronary Disease
Interventions
DEVICE

Xience Prime Stent

DEVICE

Medtronic Resolute Integrity stent

PROCEDURE

Angiography

PROCEDURE

OCT

Trial Locations (3)

3000

RECRUITING

University Hospitals Leuven, Leuven

8200

RECRUITING

Aarhus University Hspital, Aarhus N

Unknown

RECRUITING

Royal Brompton Hospital, London

Sponsors
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Medtronic

INDUSTRY

lead

Aarhus University Hospital Skejby

OTHER

NCT02234804 - The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study | Biotech Hunter | Biotech Hunter